Search Results - "de Oca Arjona, M. Montes"

Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections by Márquez‐Coello, M., Montes‐de‐Oca Arjona, M., Fernández‐Gutiérrez del Álamo, C., Ruiz‐Sánchez, C., Girón‐González, J. A.

“…Summary The objective of this study was to conduct an analysis of peripheral blood Th17 cells with the ability to home to gut mucosa (CD4+Th17+β7+) during…”
Get full text

Structured intermittent interruption of chronic HIV infection treatment with highly active antiretroviral therapy: effects on leptin and TNF-alpha by Arjona, M Montes de Oca, Pérez-Cano, R, Garcia-Juárez, R, Martín-Aspas, A, del Alamo, C Fernández Gutiérrez, Girón-González, J A

“…The changes in nutritional parameters and adipocytokines after structured intermittent interruption of highly active antiretroviral treatment of patients with…”
Get more information

Absence of favourable changes in circulating levels of interleukin-16 or β-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection by de Oca Arjona, M. Montes, Cano, R. Pérez, Orozco, M.J., Aspas, A. Martín, Guerrero, F., del Álamo, C. Fernández Gutiérrez, Girón-González, J.A.

“…Changes in virological and immunological parameters were analysed following structured intermittent interruption of highly active anti-retroviral therapy…”
Get full text

756 INTERLEUKIN 6 AS A PROGNOSTIC FACTOR IN HUMAN IMMUNODEFICIENCY VIRUS AND HEPATITIS C VIRUS CO-INFECTED PATIENTS WITH DESCOMPENSATED CIRRHOSIS by Arjona, M. Montes de Oca, Brun, F, Marquez, M, Rodriguez-Ramos, C, Terrón, A, Vergara, A, Fernández-Gutierrez, C, Girón-González, J.A

Get full text

Admissions and mortality changes in a third-level care Hospital Internal Medicine Department (1996-2000). Influence of the modifications in the HIV infection treatment by Brun Romero, F M, Martín Aspas, A, Guerrero Sánchez, F, Montes de Oca Arjona, M, Soto Cárdenas, M J, Girón González, J A

“…To analyze the impact of highly active anti-retroviral therapy (HAART) on the admissions and mortality of patients with human immunodeficiency virus (HIV)…”
Get more information